Suppr超能文献

抗癫痫药物联合使用对拉莫三嗪清除率的影响。

Effect of antiepileptic drug comedication on lamotrigine clearance.

作者信息

Weintraub David, Buchsbaum Richard, Resor Stanley R, Hirsch Lawrence J

机构信息

Columbia Comprehensive Epilepsy Center and Department of Neurology, College of Physicians and Surgeons, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.

出版信息

Arch Neurol. 2005 Sep;62(9):1432-6. doi: 10.1001/archneur.62.9.1432.

Abstract

OBJECTIVE

To investigate the effect of antiepileptic drug (AED) comedication, including all newer AEDs, on lamotrigine clearance (CL).

DESIGN

We reviewed 570 medical charts of outpatients 12 years and older seen at the Columbia Comprehensive Epilepsy Center who received lamotrigine as monotherapy or adjunctive therapy. We investigated whether a given comedication contributed to the lamotrigine serum concentration. In addition, we examined whether the mean lamotrigine CL during comedication with each AED differed from the lamotrigine CL during monotherapy. Finally, we examined whether individuals had significantly different lamotrigine CLs when taking or not taking a particular comedication.

RESULTS

Comedication with phenytoin, carbamazepine, and valproate sodium were the major AED predictors of lamotrigine serum concentration. Comedication regimens with felbamate, oxcarbazepine, and phenobarbital were small but significant predictors. The mean lamotrigine CL was 43.2 mL/h per kilogram of body weight with lamotrigine monotherapy, significantly higher with comedication with phenytoin (101.3 mL/h per kilogram) and carbamazepine (59.5 mL/h per kilogram) and significantly lower with valproate (16.9 mL/h per kilogram). Patients had significantly higher lamotrigine CL when taking phenytoin, carbamazepine, and phenobarbital than when not taking those comedications and had significantly lower lamotrigine CL when taking valproate. The mean lamotrigine CL was significantly lower than that associated with monotherapy in patients comedicated with valproate plus phenytoin (22.0 mL/h per kilogram) but not in patients comedicated with valproate plus carbamazepine (33.3 mL/h per kilogram). No other AEDs affected lamotrigine CL.

CONCLUSION

Phenytoin increases lamotrigine CL by approximately 125%, carbamazepine increases lamotrigine CL by approximately 30% to 50%, and valproate decreases lamotrigine CL by approximately 60%. No newer AED, with the possible exception of oxcarbazepine, has a major impact on lamotrigine CL.

摘要

目的

研究抗癫痫药物(AED)联合用药(包括所有新型AED)对拉莫三嗪清除率(CL)的影响。

设计

我们回顾了哥伦比亚综合癫痫中心12岁及以上门诊患者的570份病历,这些患者接受拉莫三嗪单药治疗或辅助治疗。我们调查了特定的联合用药是否会影响拉莫三嗪的血清浓度。此外,我们检查了每种AED联合用药期间拉莫三嗪的平均CL是否与单药治疗期间拉莫三嗪的CL不同。最后,我们检查了个体在服用或未服用特定联合用药时拉莫三嗪的CL是否有显著差异。

结果

与苯妥英钠、卡马西平和丙戊酸钠联合用药是拉莫三嗪血清浓度的主要AED预测因素。与非氨酯、奥卡西平和苯巴比妥联合用药方案是较小但显著的预测因素。拉莫三嗪单药治疗时,拉莫三嗪的平均CL为每千克体重43.2毫升/小时,与苯妥英钠联合用药时显著更高(每千克101.3毫升/小时),与卡马西平联合用药时(每千克59.5毫升/小时)显著更高,与丙戊酸联合用药时显著更低(每千克16.9毫升/小时)。患者服用苯妥英钠、卡马西平和苯巴比妥时的拉莫三嗪CL显著高于未服用这些联合用药时,服用丙戊酸时的拉莫三嗪CL显著更低。丙戊酸加苯妥英钠联合用药患者的拉莫三嗪平均CL显著低于单药治疗时(每千克22.0毫升/小时),但丙戊酸加卡马西平联合用药患者则不然(每千克33.3毫升/小时)。没有其他AED影响拉莫三嗪CL。

结论

苯妥英钠使拉莫三嗪CL增加约125%,卡马西平使拉莫三嗪CL增加约30%至50%,丙戊酸使拉莫三嗪CL降低约60%。除奥卡西平可能例外,没有新型AED对拉莫三嗪CL有重大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验